Association of early-preterm birth with abnormal levels of routinely collected first- and second-trimester biomarkers

American Journal of Obstetrics and Gynecology

Volumn 208, Issue 6, 2013, Pages 492.e1-492.e11

  Jelliffe Pawlowski, Laura L ^a,b   Shaw, Gary M ^c   Currier, Robert J ^a   Stevenson, David K ^c   Baer, Rebecca J ^a   O'Brodovich, Hugh M ^a   Gould, Jeffrey B ^c,d  

^a CALIFORNIA DEPARTMENT OF PUBLIC HEALTH   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d California Perinatal Quality Care Collaborative   (United States)

Author keywords

biomarker; prenatal screening; preterm birth

Indexed keywords

ALPHA FETOPROTEIN; BIOLOGICAL MARKER;

ADULT; ARTICLE; FEMALE; FIRST TRIMESTER PREGNANCY; GESTATIONAL AGE; HUMAN; MAJOR CLINICAL STUDY; PREMATURE LABOR; PRENATAL SCREENING; PRIORITY JOURNAL; SECOND TRIMESTER PREGNANCY; UNITED STATES;

EID: 84878416432     PISSN: 00029378     EISSN: 10976868     Source Type: Journal    
DOI: 10.1016/j.ajog.2013.02.012     Document Type: Article

References (48)

1. R. Smith, S. Mesiano, E.C. Chan, S. Brown, R.B. Jaffe Corticotrophin-releasing hormone directly and preferentially stimulates dehydroepiandrosterone sulfate secretion by human fetal adrenal cortical cells J Clin Endocrinol Metab 83 1998 2916 2920
2. P. Licht, V. Russu, L. Wildt On the role of human chorionic gonadotropin (hCG) in the embryo-endometrial microenvironment: implications for differentiation and implantation Semin Reprod Med 19 2001 37 47
3. R.L. Goldenberg, J.C. Hauth, W.W. Andrews Intrauterine infection and preterm delivery N Engl J Med 342 2000 1500 1507
4. K. Handschuh, J. Guibourdenche, M. Guesnon, I. Laurendeau, D. Evain-Brion, T. Fournier Modulation of PAPP-A expression by PPARgamma in human first trimester trophoblast Placenta 27 suppl A 2006 S127 S134
5. R.L. Jones, C. Stoikos, J.K. Findlay, L.A. Salamonsen TGF-beta superfamily expression and actions in the endometrium and placenta Reproduction 132 2006 217 232
6. G.J. Mizejewski Physiology of alpha-fetoprotein as a biomarker for perinatal distress: relevance to adverse pregnancy outcome Exp Biol Med (Maywood) 232 2007 993 1004
7. E.R. Norwitz Defective implantation and placentation: laying the blueprint for pregnancy complications Reprod Biomed Online 14 2007 101 109
8. R. Smith Parturition N Engl J Med 356 2007 271 283
9. T. Fournier, P. Therond, K. Handschuh, V. Tsatsaris, D. Evain-Brion PPARgamma and early human placental development Curr Med Chem 15 2008 3011 3024
10. V.K. Misra, C.J. Hobel, C.F. Sing Placental blood flow and the risk of preterm delivery Placenta 30 2009 619 624
11. R. Smith, J.I. Smith, X. Shen Patterns of plasma corticotropin-releasing hormone, progesterone, estradiol, and estriol change and the onset of human labor J Clin Endocrinol Metab 94 2009 2066 2074
12. C.M. Bilardo, E. Timmerman, E. Pajkrt, M. van Maarle Increased nuchal translucency in euploid fetuses: what should we be telling the parents? Prenat Diagn 30 2010 93 102
13. H. Ishimoto, R.B. Jaffe Development and function of the human fetal adrenal cortex: a key component in the feto-placental unit Endocr Rev 32 2011 317 355
14. B. Fitzgerald, K. Levytska, J. Kingdom, M. Walker, D. Baczyk, S. Keating Villous trophoblast abnormalities in extremely preterm deliveries with elevated second trimester maternal serum hCG or inhibin-A Placenta 32 2011 339 345
15. L. Brou, L.M. Almli, B.D. Pearce Dysregulated biomarkers induce distinct pathways in preterm birth BJOG 119 2012 458 473
16. G. Pidoux, P. Gerbaud, M. Cocquebert Review: human trophoblast fusion and differentiation: lessons from trisomy 21 placenta Placenta 33 suppl 2012 S81 S86
17. L. Dugoff, J.C. Hobbins, F.D. Malone First-trimester maternal serum PAPP-A and free-beta subunit human chorionic gonadotropin concentrations and nuchal translucency are associated with obstetric complications: a population-based screening study (the FASTER Trial) Am J Obstet Gynecol 191 2004 1446 1451
18. D. Krantz, L. Goetzl, J.L. Simpson Association of extreme first-trimester free human chorionic gonadotropin-beta, pregnancy-associated plasma protein A, and nuchal translucency with intrauterine growth restriction and other adverse pregnancy outcomes Am J Obstet Gynecol 191 2004 1452 1458
19. G.C. Smith, I. Shah, I.R. White, J.P. Pell, J.A. Crossley, R. Dobbie Maternal and biochemical predictors of spontaneous preterm birth among nulliparous women: a systematic analysis in relation to the degree of prematurity Int J Epidemiol 35 2006 1169 1177
20. G.C. Smith, I. Shah, J.A. Crossley Pregnancy-associated plasma protein A and alpha-fetoprotein and prediction of adverse perinatal outcome Obstet Gynecol 107 2006 161 166
21. L. Dugoff, J.C. Hobbins, F.D. Malone Quad screen as a predictor of adverse pregnancy outcome Obstet Gynecol 106 2005 260 267
22. K.J. Brameld, J.E. Dickinson, P. O'Leary First trimester predictors of adverse pregnancy outcomes Aust N Z J Obstet Gynaecol 48 2008 529 535
23. L. Dugoff, H.S. Cuckle, J.C. Hobbins Prediction of patient-specific risk for fetal loss using maternal characteristics and first- and second-trimester maternal serum Down syndrome markers Am J Obstet Gynecol 199 2008 290 296
24. K. Spencer, N.J. Cowans, F. Molina, K.O. Kagan, K.H. Nicolaides First-trimester ultrasound and biochemical markers of aneuploidy and the prediction of preterm or early preterm delivery Ultrasound Obstet Gynecol 31 2008 147 152
25. L. Dugoff First- and second-trimester maternal serum markers for aneuploidy and adverse obstetric outcomes Obstet Gynecol 115 2010 1052 1061
26. L.L. Jelliffe-Pawlowski, R.J. Baer, R.J. Currier Second trimester serum predictors of preterm birth in a population-based sample of low-risk pregnancies Prenat Diagn 30 2010 727 733
27. N.N. Kazerouni, B. Currier, L. Malm Triple-marker prenatal screening program for chromosomal defects Obstet Gynecol 114 2009 50 58
28. N. Wu, L.D. Platt, N. Greene, R.J. Currier Practitioner-specific medians for nuchal translucency to improve first-trimester screening performance Obstet Gynecol 119 2012 785 794
29. J.B. Gould The role of regional collaboratives: the California Perinatal Quality Care Collaborative model Clin Perinatol 37 2010 71 86
30. N.N. Kazerouni, R.J. Currier, M. Flessel Detection rate of quadruple-marker screening determined by clinical follow-up and registry data in the statewide California program, July 2007 to February 2009 Prenat Diagn 31 2011 901 906
31. Nuchal Translucency Quality Review Program About Us www.ntqr.org Accessed Oct. 12, 2012
32. Fetal Medicine Foundation Training and certification www.fetalmedicine. com Accessed Oct. 12, 2012
33. J. Piazze, M.M. Anceschi, A. Cerekja Nuchal translucency as a predictor of adverse pregnancy outcome Int J Gynaecol Obstet 98 2007 5 9
34. N.C. Sayin, M.T. Canda, N. Ahmet, S. Arda, N. Sut, F.G. Varol The association of triple-marker test results with adverse pregnancy outcomes in low-risk pregnancies with healthy newborns Arch Gynecol Obstet 277 2008 47 53
35. E.A. Perkes, R.S. Baim, K.J. Goodman, J.N. Macri Second-trimester placental changes associated with elevated maternal serum alpha-fetoprotein Am J Obstet Gynecol 144 1982 935 938
36. C.Y. Spong, A. Ghidini, C.N. Walker, M. Ossandon, J.C. Pezzullo Elevated maternal serum midtrimester alpha-fetoprotein levels are associated with fetoplacental ischemia Am J Obstet Gynecol 177 1997 1085 1087
37. T. Yamashita, A. Nakane, T. Watanabe, I. Miyoshi, N. Kasai Evidence that alpha-fetoprotein suppresses the immunological function in transgenic mice Biochem Biophys Res Commun 201 1994 1154 1159
38. A.I. Potapovich, S. Pastore, V.A. Kostyuk Alpha-fetoprotein as a modulator of the pro-inflammatory response of human keratinocytes Br J Pharmacol 158 2009 1236 1237
39. O. Shynlova, P. Tsui, S. Jaffer, S.J. Lye Integration of endocrine and mechanical signals in the regulation of myometrial functions during pregnancy and labour Eur J Obstet Gynecol Reprod Biol 144 suppl 1 2009 S2 S10
40. V.A. Rosenberg, I.A. Buhimschi, A.T. Dulay Modulation of amniotic fluid activin-a and inhibin-a in women with preterm premature rupture of the membranes and infection-induced preterm birth Am J Reprod Immunol 67 2012 122 131
41. K. Jain, V. Kavi, C.V. Raghuveer, R. Sinha Placental pathology in pregnancy-induced hypertension (PIH) with or without intrauterine growth retardation Indian J Pathol Microbiol 50 2007 533 537
42. Y. Matsuda, K. Hayashi, A. Shiozaki, Y. Kawamichi, S. Satoh, S. Saito Comparison of risk factors for placental abruption and placenta previa: case-cohort study J Obstet Gynaecol Res 37 2011 538 546
43. M. Furuya, J. Ishida, I. Aoki, A. Fukamizu Pathophysiology of placentation abnormalities in pregnancy-induced hypertension Vasc Health Risk Manag 4 2008 1301 1313
44. H.A. Hadi Fetal cerebral maturation in hypertensive disorders of pregnancy Obstet Gynecol 63 1984 214 219
45. B.A. Miller, R.S. Perez, A.R. Shah, E.R. Gonzales, T.S. Park, J.M. Gidday Cerebral protection by hypoxic preconditioning in a murine model of focal ischemia-reperfusion Neuroreport 12 2001 1663 1669
46. J.S. Dashe, D.D. McIntire, M.J. Lucas, K.J. Leveno Effects of symmetric and asymmetric fetal growth on pregnancy outcomes Obstet Gynecol 96 2000 321 327
47. P.Y. Ancel, S. Marret, B. Larroque Are maternal hypertension and small-for-gestational age risk factors for severe intraventricular hemorrhage and cystic periventricular leukomalacia? Results of the EPIPAGE cohort study Am J Obstet Gynecol 193 2005 178 184
48. A.K. Ewer, A.T. Furmston, L.J. Middleton Pulse oximetry as a screening test for congenital heart defects in newborn infants: a test accuracy study with evaluation of acceptability and cost-effectiveness Health Technol Assess 16 2012 v xii 1-184